<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68594-027-99
</NDCCode>
<PackageDescription>
5000 mg in 1 BAG (68594-027-99)
</PackageDescription>
<NDC11Code>
68594-0027-99
</NDC11Code>
<ProductNDC>
68594-027
</ProductNDC>
<ProductTypeName>
VACCINE
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Mnb Rlp2086 Subfamily A Protein
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20141029
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Boehringer Ingelheim RCV GmbH & Co KG
</LabelerName>
<SubstanceName>
NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN
</SubstanceName>
<StrengthNumber>
.06
</StrengthNumber>
<StrengthUnit>
mg/.06mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-02-28
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
29-OCT-14
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>